| scholarly article | Q13442814 |
| P2093 | author name string | Ribeiro J | |
| Modi G | |||
| Sacks DL | |||
| Belkaid Y | |||
| Kamhawi S | |||
| Noben-Trauth N | |||
| Rowton E | |||
| Valenzuela J | |||
| P2860 | cites work | Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells | Q24316370 |
| A mouse model of Leishmania braziliensis braziliensis infection produced by coinjection with sand fly saliva | Q27482638 | ||
| Role of saliva in blood-feeding by arthropods | Q29868693 | ||
| Establishment of a germ-line competent C57BL/6 embryonic stem cell line | Q34991986 | ||
| Keratinocyte-derived tumor necrosis factor and the physiopathology of the skin | Q35427301 | ||
| Effects of sand fly vector saliva on development of cutaneous lesions and the immune response to Leishmania braziliensis in BALB/c mice. | Q35533110 | ||
| Modulation of cytokine expression by CD4+ T cells during coxsackievirus B3 infections of BALB/c mice initiated by cells expressing the gamma delta + T-cell receptor | Q35860309 | ||
| Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major | Q36380692 | ||
| Analysis of enhancing effect of sand fly saliva on Leishmania infection in mice | Q36962942 | ||
| Sand fly vector saliva selectively modulates macrophage functions that inhibit killing of Leishmania major and nitric oxide production. | Q39042182 | ||
| Effects of Ixodes scapularis and Borrelia burgdorferi on modulation of the host immune response: induction of a TH2 cytokine response in Lyme disease-susceptible (C3H/HeJ) mice but not in disease-resistant (BALB/c) mice | Q39830565 | ||
| Tick-host immunology: Significant advances and challenging opportunities | Q40493433 | ||
| Efficient targeting of the IL-4 gene in a BALB/c embryonic stem cell line | Q41156978 | ||
| Inhibition of mosquito salivary gland apyrase activity by antibodies produced in mice immunized by bites of Anopheles stephensi mosquitoes | Q41161215 | ||
| Cytokine-mediated communication by keratinocytes and Langerhans cells with dendritic epidermal T cells | Q41265188 | ||
| Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. | Q41346251 | ||
| An innate view of gamma delta T cells | Q41353123 | ||
| Activation of murine epidermal TCR-gamma delta+ T cells by keratinocytes treated with contact sensitizers. | Q42277931 | ||
| Barrier disruption increases gene expression of cytokines and the 55 kD TNF receptor in murine skin | Q42440626 | ||
| IL-4-deficient Balb/c mice resist infection with Leishmania major | Q42943751 | ||
| Cross-reactivity of skin and serum specific IgE responses and allergen analysis for three mosquito species with worldwide distribution | Q42984459 | ||
| Are we really allergic to mosquito bites? | Q43041621 | ||
| In vivo cytokine production in murine listeriosis. Evidence for immunoregulation by gamma delta+ T cells | Q43748548 | ||
| A prospective study of naturally acquired sensitization and subsequent desensitization to mosquito bites and concurrent antibody responses | Q44138474 | ||
| Salivary gland lysate from the sand fly Lutzomyia longipalpis suppresses the immune response of mice to sheep red blood cells in vivo and concanavalin A in vitro | Q48035677 | ||
| Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity. | Q52461534 | ||
| The effect of post-bloodmeal nutrition of Phlebotomus papatasi on the transmission of Leishmania major. | Q52464926 | ||
| Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. | Q54265963 | ||
| IL-4 Rapidly Produced by Vβ4 Vα8 CD4+ T Cells Instructs Th2 Development and Susceptibility to Leishmania major in BALB/c Mice | Q56987174 | ||
| Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo | Q59054431 | ||
| A method to recover, enumerate and identify lymphomyeloid cells present in an inflammatory dermal site: a study in laboratory mice | Q60211995 | ||
| Parasitism of epidermal Langerhans cells in experimental cutaneous leishmaniasis with Leishmania major | Q70531764 | ||
| Susceptibility to Leishmania major infection in interleukin-4-deficient mice | Q70960225 | ||
| Resistance to cutaneous leishmaniasis in genetically susceptible BALB/c mice | Q71061384 | ||
| IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses | Q71079171 | ||
| Leishmania major: effect of infectious dose on T cell subset development in BALB/c mice | Q71810299 | ||
| In vitro production of interleukin-4 and interferon-gamma by lymph node cells from BALB/c mice infested with nymphal Ixodes ricinus ticks | Q71959123 | ||
| IFN-gamma IL-2, and IL-4 mRNA expression in the skin and draining lymph nodes of BALB/c mice repeatedly infested with nymphal Ixodes ricinus ticks | Q72496737 | ||
| Thy-1 Antigen-Bearing Dendritic Cells Populate Murine Epidermis | Q72559920 | ||
| The effect of anti-sandfly saliva antibodies on Phlebotomus argentipes and Leishmania donovani | Q74346357 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | saliva | Q155925 |
| Leishmania major | Q1950715 | ||
| vector-borne disease | Q2083837 | ||
| cutaneous leishmaniasis | Q2590966 | ||
| P304 | page(s) | 1941-1953 | |
| P577 | publication date | 1998-11-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis | |
| P478 | volume | 188 |
| Q33899733 | A Listeria monocytogenes-based vaccine that secretes sand fly salivary protein LJM11 confers long-term protection against vector-transmitted Leishmania major |
| Q44462043 | A follow-up of Beagle dogs intradermally infected with Leishmania chagasi in the presence or absence of sand fly saliva |
| Q52687615 | A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs. |
| Q42670769 | A live Leishmania major vaccine containing CpG motifs induces the de novo generation of Th17 cells in C57BL/6 mice. |
| Q52536969 | A method for the isolation and analysis of leucocytic cells from Leishmanial ear lesions in mice. |
| Q36702606 | A new model of progressive visceral leishmaniasis in hamsters by natural transmission via bites of vector sand flies |
| Q33671863 | A scoring method to standardize lesion monitoring following intra-dermal infection of Leishmania parasites in the murine ear. |
| Q34341332 | Aberrant host defense against Leishmania major in the absence of SLPI. |
| Q34418968 | Analysis of salivary gland transcripts of the sand fly Lutzomyia ayacuchensis, a vector of Andean-type cutaneous leishmaniasis |
| Q33859617 | Animal models for the study of leishmaniasis immunology. |
| Q52671037 | Antibodies against Lutzomyia longipalpis saliva in the fox Cerdocyon thous and the sylvatic cycle of Leishmania chagasi. |
| Q35618935 | Association of human immune response to Aedes aegypti salivary proteins with dengue disease severity |
| Q33633286 | BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge |
| Q35974756 | Biomarkers for exposure to sand flies bites as tools to aid control of leishmaniasis |
| Q28748688 | BluePort: a platform to study the eosinophilic response of mice to the bite of a vector of Leishmania parasites, Lutzomyia longipalpis sand flies |
| Q28588634 | CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 c |
| Q39430356 | Canine experimental infection: intradermal inoculation of Leishmania infantum promastigotes. |
| Q38100045 | Case study for a vaccine against leishmaniasis |
| Q34875390 | Characterization of the antibody response to the saliva of Phlebotomus papatasi in people living in endemic areas of cutaneous leishmaniasis |
| Q35156699 | Characterization of the early inflammatory infiltrate at the feeding site of infected sand flies in mice protected from vector-transmitted Leishmania major by exposure to uninfected bites |
| Q47096541 | Clinical and immunopathological findings during long term follow-up in Leishmania infantum experimentally infected dogs |
| Q35802037 | Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous Leishmaniasis but maintains its potency and durability |
| Q35571431 | Coinjection with TLR2 agonist Pam3CSK4 reduces the pathology of leishmanization in mice. |
| Q35126526 | Colonization of Phlebotomus papatasi changes the effect of pre-immunization with saliva from lack of protection towards protection against experimental challenge with Leishmania major and saliva |
| Q34595909 | Comparative evaluation of lesion development, tissue damage, and cytokine expression in golden hamsters (Mesocricetus auratus) infected by inocula with different Leishmania (Viannia) braziliensis concentrations |
| Q37410053 | Comparative evaluation of two vaccine candidates against experimental leishmaniasis due to Leishmania major infection in four inbred mouse strains. |
| Q36889371 | Comparative genomics: from genotype to disease phenotype in the leishmaniases |
| Q33236620 | Comparative salivary gland transcriptomics of sandfly vectors of visceral leishmaniasis |
| Q35745620 | Comparison of Models for Bubonic Plague Reveals Unique Pathogen Adaptations to the Dermis |
| Q33946585 | Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection |
| Q98944131 | Conserved and distinct morphological aspects of the salivary glands of sand fly vectors of leishmaniasis: an anatomical and ultrastructural study |
| Q51806512 | Considerations on the effect of anti-sandfly antibodies on biological parameters of Lutzomyia longipalpis (Lutz & Neiva, 1912) (Diptera: Psychodidae: Phlebotominae). |
| Q40115071 | Control of Regulatory T Cell Differentiation by the Transcription Factors Thpok and LRF. |
| Q33494518 | Cooperative blood-feeding and the function and implications of feeding aggregations in the sand fly, Lutzomyia longipalpis (Diptera: Psychodidae). |
| Q34601558 | Cross-species genetic exchange between visceral and cutaneous strains of Leishmania in the sand fly vector |
| Q28072094 | Crosstalk between purinergic receptors and lipid mediators in leishmaniasis |
| Q36915067 | DNA Vaccines against Protozoan Parasites: Advances and Challenges |
| Q61796921 | DNA plasmid coding for Phlebotomus sergenti salivary protein PsSP9, a member of the SP15 family of proteins, protects against Leishmania tropica |
| Q37106270 | DNA vaccination with KMP11 and Lutzomyia longipalpis salivary protein protects hamsters against visceral leishmaniasis |
| Q33518485 | Degradation of host sphingomyelin is essential for Leishmania virulence. |
| Q30876085 | Delayed-type hypersensitivity to Phlebotomus papatasi sand fly bite: An adaptive response induced by the fly? |
| Q36488101 | Delayed-type hypersensitivity to sand fly saliva in humans from a leishmaniasis-endemic area of Mali is Th1-mediated and persists to midlife |
| Q37117038 | Dendritic cell populations in Leishmania major-infected skin and draining lymph nodes |
| Q35865823 | Dengue and soluble mediators of the innate immune system |
| Q40422839 | Detailed analysis of an experimental challenge model for Leishmania infantum (JPC strain) in dogs |
| Q38468623 | Development of a Murine Infection Model with Leishmania killicki, Responsible for Cutaneous Leishmaniosis in Algeria: Application in Pharmacology. |
| Q34620299 | Differential antibody response to the Anopheles gambiae gSG6 and cE5 salivary proteins in individuals naturally exposed to bites of malaria vectors |
| Q39547242 | Drug permeation and barrier damage in Leishmania-infected mouse skin |
| Q34711299 | Dual effect of Lutzomyia longipalpis saliva on Leishmania braziliensis infection is mediated by distinct saliva-induced cellular recruitment into BALB/c mice ear |
| Q52658620 | Effect of salivary gland extract of Leishmania vector, Lutzomyia longipalpis, on leukocyte migration in OVA-induced immune peritonitis. |
| Q101121083 | Engineering a vector-based pan-Leishmania vaccine for humans: proof of principle |
| Q33308759 | Enhanced Leishmania braziliensis infection following pre-exposure to sandfly saliva |
| Q44168829 | Epidemiological consequences of immune sensitisation by pre-exposure to vector saliva |
| Q34160109 | Epidemiological study of the association between anti-Lutzomyia longipalpis saliva antibodies and development of delayed-type hypersensitivity to Leishmania antigen |
| Q37270131 | Evaluation of T cell responses in healing and nonhealing leishmaniasis reveals differences in T helper cell polarization ex vivo and in vitro |
| Q27481262 | Evaluation of antibody response to Plasmodium falciparum in children according to exposure of Anopheles gambiae s.l or Anopheles funestus vectors |
| Q34256724 | Evaluation of the murine immune response to Xenopsylla cheopis flea saliva and its effect on transmission of Yersinia pestis |
| Q37167717 | Experimental infection of Phlebotomus perniciosus by bioluminescent Leishmania infantum using murine model and artificial feeder |
| Q34663797 | Experimental infection of dogs with Leishmania and saliva as a model to study Canine Visceral Leishmaniasis |
| Q37371348 | Experimental models in vaccine research: malaria and leishmaniasis |
| Q35841537 | Expression, purification, crystallization and crystallographic study of Lutzomyia longipalpis LJL143. |
| Q34648165 | First comparative transcriptomic analysis of wild adult male and female Lutzomyia longipalpis, vector of visceral leishmaniasis |
| Q52584373 | Flying doctors. |
| Q33223107 | From transcriptome to immunome: identification of DTH inducing proteins from a Phlebotomus ariasi salivary gland cDNA library |
| Q46191394 | Genetic variation in the sand fly salivary protein, SP-15, a potential vaccine candidate against Leishmania major |
| Q59811816 | Genomic Analysis of Colombian Leishmania panamensis strains with different level of virulence |
| Q36338123 | Haematophagous arthropod saliva and host defense system: a tale of tear and blood |
| Q33256324 | High degree of conservancy among secreted salivary gland proteins from two geographically distant Phlebotomus duboscqi sandflies populations (Mali and Kenya). |
| Q30847539 | High-throughput approaches to study salivary proteins and genes from vectors of disease |
| Q43920033 | Histopathological analysis of initial cellular response in TLR-2 deficient mice experimentally infected by Leishmania (L.) amazonensis. |
| Q30843522 | Hitchhiking of host biology by beneficial symbionts enhances transmission |
| Q61810435 | Host competence of African rodents and for |
| Q51970673 | Human anti-saliva immune response following experimental exposure to the visceral leishmaniasis vector, Lutzomyia longipalpis. |
| Q45412433 | Human cellular and humoral immune responses to Phlebotomus papatasi salivary gland antigens in endemic areas differing in prevalence of Leishmania major infection |
| Q31032971 | Human cellular immune response to the saliva of Phlebotomus papatasi is mediated by IL-10-producing CD8+ T cells and Th1-polarized CD4+ lymphocytes |
| Q38869588 | Human immune response to salivary proteins of wild-caught Phlebotomus papatasi. |
| Q27486947 | Hyaluronidase of Bloodsucking Insects and Its Enhancing Effect on Leishmania Infection in Mice |
| Q33693899 | Identifying vaccine targets for anti-leishmanial vaccine development |
| Q34608905 | Immune responses of a native and an invasive bird to Buggy Creek Virus (Togaviridae: Alphavirus) and its arthropod vector, the swallow bug (Oeciacus vicarius). |
| Q55262014 | Immunity to LuloHya and Lundep, the salivary spreading factors from Lutzomyia longipalpis, protects against Leishmania major infection. |
| Q33608744 | Immunity to Lutzomyia intermedia saliva modulates the inflammatory environment induced by Leishmania braziliensis |
| Q36182015 | Immunity to Lutzomyia whitmani Saliva Protects against Experimental Leishmania braziliensis Infection |
| Q36678092 | Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model. |
| Q33328462 | Immunity to distinct sand fly salivary proteins primes the anti-Leishmania immune response towards protection or exacerbation of disease |
| Q36288318 | Immunity to sand fly salivary protein LJM11 modulates host response to vector-transmitted leishmania conferring ulcer-free protection |
| Q38342966 | Immunity to visceral leishmaniasis using genetically defined live-attenuated parasites |
| Q47645608 | Immunization with LJM11 salivary protein protects against infection with Leishmania braziliensis in the presence of Lutzomyia longipalpis saliva. |
| Q44161140 | Immunological consequences of arthropod vector-derived salivary factors |
| Q33327586 | Immunomodulation of human monocytes following exposure to Lutzomyia intermedia saliva |
| Q28510289 | Immunomodulatory effects associated with a live vaccine against Leishmania major containing CpG oligodeoxynucleotides |
| Q44544983 | Immunomodulatory effects of Maxadilan and Phlebotomus papatasi sand fly salivary gland lysates on human primary in vitro immune responses |
| Q36111326 | Impact of LbSapSal Vaccine in Canine Immunological and Parasitological Features before and after Leishmania chagasi-Challenge. |
| Q42189078 | Impact of mosquito bites on asexual parasite density and gametocyte prevalence in asymptomatic chronic Plasmodium falciparum infections and correlation with IgE and IgG titers |
| Q44169521 | Impact of phlebotomine sand flies on U.S. Military operations at Tallil Air Base, Iraq: 1. background, military situation, and development of a "Leishmaniasis Control Program". |
| Q35398192 | Implication of haematophagous arthropod salivary proteins in host-vector interactions |
| Q40283583 | Increased Transmissibility of Leishmania donovani From the Mammalian Host to Vector Sand Flies After Multiple Exposures to Sand Fly Bites |
| Q34009085 | Infection parameters in the sand fly vector that predict transmission of Leishmania major |
| Q27010187 | Innate immunity against Leishmania infections |
| Q38680919 | Insights into the sand fly saliva: Blood-feeding and immune interactions between sand flies, hosts, and Leishmania |
| Q35965262 | Interleukin 10-Dominant Immune Response and Increased Risk of Cutaneous Leishmaniasis After Natural Exposure to Lutzomyia intermedia Sand Flies. |
| Q34002747 | Interleukin-4-independent acceleration of cutaneous leishmaniasis in susceptible BALB/c mice following treatment with anti-CTLA4 antibody |
| Q34521577 | Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis |
| Q58824983 | Intramuscular immunization with p36(LACK) DNA vaccine induces IFN-γ production but does not protect BALB/c mice against Leishmania chagasi intravenous challenge |
| Q26865242 | Is arthropod saliva the achilles' heel of vector-borne diseases? |
| Q33991563 | Kinetic analysis of ex vivo human blood infection by Leishmania |
| Q34339785 | Kinetics of antibody response in BALB/c and C57BL/6 mice bitten by Phlebotomus papatasi |
| Q37619168 | LBSapSal-vaccinated dogs exhibit increased circulating T-lymphocyte subsets (CD4⁺ and CD8⁺) as well as a reduction of parasitism after challenge with Leishmania infantum plus salivary gland of Lutzomyia longipalpis. |
| Q34087315 | Lack of protection of pre-immunization with saliva of long-term colonized Phlebotomus papatasi against experimental challenge with Leishmania major and saliva of wild-caught P. papatasi. |
| Q40617752 | Leishmania (Leishmania) amazonensis-induced cutaneous leishmaniasis in the primate Cebus apella: a model for vaccine trials |
| Q21131306 | Leishmania RNA virus: when the host pays the toll |
| Q36820548 | Leishmania and the leishmaniases: a parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans |
| Q41951214 | Leishmania braziliensis and Leishmania amazonensis amastigote extracts differ in their enhancement effect on Leishmania infection when injected intradermally |
| Q35030191 | Leishmania enriettii: biochemical characterisation of lipophosphoglycans (LPGs) and glycoinositolphospholipids (GIPLs) and infectivity to Cavia porcellus |
| Q34772767 | Leishmania major attenuates host immunity by stimulating local indoleamine 2,3-dioxygenase expression |
| Q37727290 | Leishmania major inhibits IL-12 in macrophages by signalling through CR3 (CD11b/CD18) and down-regulation of ETS-mediated transcription |
| Q34005112 | Leishmania major reaches distant cutaneous sites where it persists transiently while persisting durably in the primary dermal site and its draining lymph node: a study with laboratory mice |
| Q35093068 | Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity |
| Q34257759 | Leishmania pifanoi pathogenesis: selective lack of a local cutaneous response in the absence of circulating antibody |
| Q36399080 | Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells |
| Q35208878 | Lutzomyia longipalpis (Diptera: Psychodidae: Phlebotominae): a review |
| Q27306221 | Lutzomyia longipalpis saliva or salivary protein LJM19 protects against Leishmania braziliensis and the saliva of its vector, Lutzomyia intermedia |
| Q36576090 | Lutzomyia longipalpis salivary gland homogenate impairs cytokine production and costimulatory molecule expression on human monocytes and dendritic cells |
| Q36712427 | Lutzomyia longipalpis salivary peptide maxadilan alters murine dendritic cell expression of CD80/86, CCR7, and cytokine secretion and reprograms dendritic cell-mediated cytokine release from cultures containing allogeneic T cells |
| Q59138115 | Macrophage Polarization in Leishmaniasis: Broadening Horizons |
| Q48107825 | Mannose receptor high, M2 dermal macrophages mediate nonhealing Leishmania major infection in a Th1 immune environment. |
| Q44198128 | Maxadilan, the vasodilator/immunomodulator from Lutzomyia longipalpis sand fly saliva, stimulates haematopoiesis in mice |
| Q27010243 | Mechanisms of cellular invasion by intracellular parasites |
| Q35294714 | Meta-analysis of the effects of insect vector saliva on host immune responses and infection of vector-transmitted pathogens: a focus on leishmaniasis |
| Q46779264 | Modulation of murine cellular immune response and cytokine production by salivary gland lysate of three sand fly species |
| Q26314450 | Molecular Diversity between Salivary Proteins from New World and Old World Sand Flies with Emphasis on Bichromomyia olmeca, the Sand Fly Vector of Leishmania mexicana in Mesoamerica |
| Q33876004 | Monitoring the efficacy of antimicrobial photodynamic therapy in a murine model of cutaneous leishmaniasis using L. major expressing GFP. |
| Q24655645 | Mosquito Saliva Increases Endothelial Permeability in the Skin, Immune Cell Migration, and Dengue Pathogenesis during Antibody-Dependent Enhancement |
| Q27686928 | Mouse models for pathogenic African trypanosomes: unravelling the immunology of host-parasite-vector interactions. |
| Q37293213 | Natural Mosquito-Pathogen Hybrid IgG4 Antibodies in Vector-Borne Diseases: A Hypothesis |
| Q36357924 | Natural transmission of Leishmania infantum through experimentally infected Phlebotomus perniciosus highlights the virulence of Leishmania parasites circulating in the human visceral leishmaniasis outbreak in Madrid, Spain |
| Q36871944 | New Insights Into the Transmissibility of Leishmania infantum From Dogs to Sand Flies: Experimental Vector-Transmission Reveals Persistent Parasite Depots at Bite Sites |
| Q35838090 | New Insights on the Inflammatory Role of Lutzomyia longipalpis Saliva in Leishmaniasis |
| Q35539678 | No recent adaptive selection on the apyrase of Mediterranean Phlebotomus: implications for using salivary peptides to vaccinate against canine leishmaniasis |
| Q35368022 | Nucleosides from Phlebotomus papatasi salivary gland ameliorate murine collagen-induced arthritis by impairing dendritic cell functions. |
| Q35300310 | Nucleosides present on phlebotomine saliva induce immunossuppression and promote the infection establishment. |
| Q52009810 | Optimization of DNA vaccination against cutaneous leishmaniasis. |
| Q40109611 | Parasiticidal effect of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis is indirect and mediated through the killing of the host cells. |
| Q33826891 | Pathogen-tick-host interactions: Borrelia burgdorferi and TBE virus |
| Q92802114 | Pathological roles of MRP14 in anemia and splenomegaly during experimental visceral leishmaniasis |
| Q35011520 | Perforin and gamma interferon are critical CD8+ T-cell-mediated responses in vaccine-induced immunity against Leishmania amazonensis infection |
| Q35227682 | Phlebotomine salivas inhibit immune inflammation-induced neutrophil migration via an autocrine DC-derived PGE2/IL-10 sequential pathway |
| Q47622452 | Phlebotomus papatasi Yellow-Related and Apyrase Salivary Proteins Are Candidates for Vaccination against Human Cutaneous Leishmaniasis. |
| Q52627170 | Population genetics analysis of Phlebotomus papatasi sand flies from Egypt and Jordan based on mitochondrial cytochrome b haplotypes. |
| Q28748982 | Postgenomic research on leishmaniasis: a critical self-appraisal |
| Q47137387 | Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis |
| Q21144412 | Prior exposure to uninfected mosquitoes enhances mortality in naturally-transmitted West Nile virus infection |
| Q36483578 | Proapoptotic Bcl-2 family member Bim promotes persistent infection and limits protective immunity |
| Q89764824 | Process Characterization and Biophysical Analysis for a Yeast-Expressed Phlebotomus papatasi Salivary Protein (PpSP15) as a Leishmania Vaccine Candidate |
| Q33588558 | Profiling of human acquired immunity against the salivary proteins of Phlebotomus papatasi reveals clusters of differential immunoreactivity. |
| Q92888016 | Promastigote secretory gel from natural and unnatural sand fly vectors exacerbate Leishmania major and Leishmania tropica cutaneous leishmaniasis in mice |
| Q34808101 | Prostaglandin E2/leukotriene B4 balance induced by Lutzomyia longipalpis saliva favors Leishmania infantum infection |
| Q28469147 | Protection against Mycobacterium ulcerans lesion development by exposure to aquatic insect saliva |
| Q33495567 | Proteophosophoglycans regurgitated by Leishmania-infected sand flies target the L-arginine metabolism of host macrophages to promote parasite survival |
| Q27319532 | Rapid Sequestration of Leishmania mexicana by Neutrophils Contributes to the Development of Chronic Lesion |
| Q37464870 | Repeated exposure to Lutzomyia intermedia sand fly saliva induces local expression of interferon-inducible genes both at the site of injection in mice and in human blood |
| Q43215344 | Rhesus monkey model for Leishmania major transmitted by Phlebotomus papatasi sandfly bites |
| Q36399862 | Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity |
| Q36884480 | Role of sand fly saliva in human and experimental leishmaniasis: current insights |
| Q91999810 | Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis |
| Q41616344 | Salivary gland homogenates from wild-caught sand flies Lutzomyia flaviscutellata and Lutzomyia (Psychodopygus) complexus showed inhibitory effects on Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis infection in BALB/c mice. |
| Q34282246 | Salivary gland transcriptomes and proteomes of Phlebotomus tobbi and Phlebotomus sergenti, vectors of leishmaniasis |
| Q37162773 | Sand flies, Leishmania, and transcriptome-borne solutions |
| Q36576052 | Sand fly saliva enhances Leishmania amazonensis infection by modulating interleukin-10 production |
| Q33450546 | Sand fly salivary proteins induce strong cellular immunity in a natural reservoir of visceral leishmaniasis with adverse consequences for Leishmania |
| Q28662255 | Sand fly-Leishmania interactions: long relationships are not necessarily easy |
| Q37321931 | Sand-fly saliva-leishmania-man: the trigger trio |
| Q36744273 | Seasonal and Physiological Variations of Phlebotomus papatasi Salivary Gland Antigens in Central Iran |
| Q51800445 | Setting new immunobiological parameters in the hamster model of visceral leishmaniasis for in vivo testing of antileishmanial compounds. |
| Q39616365 | Sibling species in the Llutzomyia longipalpis complex differ in levels of mRNA expression for the salivary peptide, maxadilan |
| Q63198732 | Silent infection of bone marrow-derived dendritic cells byLeishmania mexicana amastigotes |
| Q29247940 | Structure of SALO, a leishmaniasis vaccine candidate from the sand fly Lutzomyia longipalpis |
| Q26766230 | Study of Leishmania pathogenesis in mice: experimental considerations |
| Q33732035 | Synthetic glycovaccine protects against the bite of leishmania-infected sand flies. |
| Q33725698 | Systemic FasL and TRAIL neutralisation reduce leishmaniasis induced skin ulceration |
| Q36788745 | The Nlrp3 inflammasome, IL-1β, and neutrophil recruitment are required for susceptibility to a nonhealing strain of Leishmania major in C57BL/6 mice |
| Q40044852 | The Sand Fly Salivary Protein Lufaxin Inhibits the Early Steps of the Alternative Pathway of Complement by Direct Binding to the Proconvertase C3b-B. |
| Q39796781 | The antituberculosis drug pyrazinamide affects the course of cutaneous leishmaniasis in vivo and increases activation of macrophages and dendritic cells. |
| Q34117495 | The biological and immunomodulatory properties of sand fly saliva and its role in the establishment of Leishmania infections |
| Q33799813 | The host response to Leishmania infection. |
| Q35952185 | The immune response to sand fly salivary proteins and its influence on leishmania immunity |
| Q34988360 | The immunology of susceptibility and resistance to Leishmania major in mice |
| Q36423181 | The immunomodulatory factors of arthropod saliva and the potential for these factors to serve as vaccine targets to prevent pathogen transmission |
| Q33962295 | The immunomodulatory factors of bloodfeeding arthropod saliva |
| Q35177839 | The importance of CD11b+ dendritic cells in CD4+ T cell activation in vivo: with help from interleukin 1. |
| Q35513962 | The innate and adaptive response to mosquito saliva and Plasmodium sporozoites in the skin |
| Q35207494 | The role of CD4(+)CD25(+) regulatory T cells in Leishmania infection |
| Q36370082 | The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. |
| Q36063617 | The role of leishmania proteophosphoglycans in sand fly transmission and infection of the Mammalian host |
| Q36655180 | The route of Leishmania tropica infection determines disease outcome and protection against Leishmania major in BALB/c mice |
| Q43727126 | The salivary adenosine/AMP content of Phlebotomus argentipes Annandale and Brunetti, the main vector of human kala-azar |
| Q34944681 | The site of Leishmania major infection determines disease severity and immune responses |
| Q26752781 | The site of the bite: Leishmania interaction with macrophages, neutrophils and the extracellular matrix in the dermis |
| Q36816174 | The skin as interface in the transmission of arthropod-borne pathogens |
| Q36153258 | Tick-host interactions: saliva-activated transmission. |
| Q36369425 | Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein |
| Q34033888 | Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis |
| Q27486488 | Toward an understanding of the biochemical and pharmacological complexity of the saliva of a hematophagous sand fly Lutzomyia longipalpis |
| Q92072049 | Transcriptome Analysis Identifies Immune Markers Related to Visceral Leishmaniasis Establishment in the Experimental Model of BALB/c Mice |
| Q33714994 | Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG. |
| Q35217499 | Tsetse fly saliva accelerates the onset of Trypanosoma brucei infection in a mouse model associated with a reduced host inflammatory response |
| Q27024973 | Tsetse fly saliva: Could it be useful in fly infection when feeding in chronically aparasitemic mammalian hosts |
| Q48020852 | Two waves of antigen-containing dendritic cells in vivo in experimental Leishmania major infection |
| Q35784007 | Uninfected mosquito bites confer protection against infection with malaria parasites |
| Q34471790 | Updating the salivary gland transcriptome of Phlebotomus papatasi (Tunisian strain): the search for sand fly-secreted immunogenic proteins for humans |
| Q47290243 | Use of In Vivo Imaging System Technology in Leishmania major BALB/c Mouse Ear Infection Studies |
| Q39257463 | Use of two-photon microscopy to study Leishmania major infection of the skin |
| Q37220376 | Vaccination with photodynamic therapy-treated macrophages induces highly suppressive T-regulatory cells |
| Q34033949 | Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice |
| Q30425005 | Vaccines to combat the neglected tropical diseases |
| Q34019064 | Vector saliva in vaccines for visceral leishmaniasis: a brief encounter of high consequence? |
| Q27316727 | Vector transmission of leishmania abrogates vaccine-induced protective immunity |
| Q28607896 | What's behind a sand fly bite? The profound effect of sand fly saliva on host hemostasis, inflammation and immunity |
| Q58863579 | Wound healing response is a major contributor to the severity of cutaneous leishmaniasis in the ear model of infection |
Search more.